Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04369716 · ClinicalTrials.gov registry record · NA

The Impact of Fruit Juice, Fruit Juice With Pomace, or Whole Fruit on Glycemic Response

A NA study of Glycemic Response, sponsored by PepsiCo Global R&D.

Completed
Registry status
NA
Development phase
18
Enrollment target
1
Study location

NCT04369716: Completed NA study of Glycemic Response, sponsored by PepsiCo Global R&D.

NCT04369716 is a NA study of Glycemic Response that has completed, run by PepsiCo Global R&D. The registered enrollment target is 18 participants, below the 314-participant average among 4 other Glycemic Response trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04369716, a NA study of Glycemic Response, has completed, sponsored by PepsiCo Global R&D.

COMPLETED
Registry status
NA
Development phase
18 participants
Enrollment target
1
Study location

Study Summary

The primary aim of this clinical trial is to compare the effects of a whole orange, orange juice alone, and orange juice with pomace, and a whole apple, apple juice alone, apple juice with pomace on glycemic response. Fruit pomace is a fiber-rich byproduct that is isolated during normal juice production of fruits, such as orange and apple.

Primary Outcome

Blood serum

Conditions Studied

Interventions

  • OTHER Whole oranges
  • OTHER Whole Apples
  • OTHER Orange juice + orange pomace
  • OTHER Apple juice + apple pomace
  • OTHER Orange juice

Study Locations (1)

Illinois

  • BioFortis Innovation Services - Addison

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2017-10-09
Est. Completion 2017-12-23
Phase NA
PepsiCo Global R&D

47 total trials

What the finished NCT04369716 record still lists

NCT04369716 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 314-participant average among 4 other Glycemic Response trials with a reported enrollment target (94% lower).

The record links to 1 condition, with Glycemic Response appearing as the primary indexed condition, and to 5 interventions - of which Whole oranges is the first listed.

NCT04369716 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT04369716 about?

NCT04369716 is a clinical study titled "The Impact of Fruit Juice, Fruit Juice With Pomace, or Whole Fruit on Glycemic Response". The primary aim of this clinical trial is to compare the effects of a whole orange, orange juice alone, and orange juice with pomace, and a whole apple, apple juice alone, apple juice with pomace on glycemic response. Fruit pomace is a fiber-rich byproduct that is isolated during normal juice produc...

What is the current status of trial NCT04369716?

This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2017-10-09. Estimated completion is 2017-12-23.

What conditions does trial NCT04369716 study?

This clinical trial studies the following conditions: Glycemic Response.

What interventions are being tested in trial NCT04369716?

The interventions under investigation include: Whole oranges (OTHER), Whole Apples (OTHER), Orange juice + orange pomace (OTHER), Apple juice + apple pomace (OTHER), Orange juice (OTHER).

Who is sponsoring clinical trial NCT04369716?

This trial is sponsored by PepsiCo Global R&D, which has 47 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04369716 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Glycemic Response

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01245179 · 18 participants · Phase 1

    Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease

  • NCT01999361 · 18 participants · NA

    Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss

  • NCT02359825 · 18 participants · Phase 1

    Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function

  • NCT02870244 · 18 participants · Phase 1

    Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04369716, the US trial registry maintained by the National Library of Medicine. NCT04369716 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.